Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Celldex Therapeutics, Inc. Director's Dealing 2025

Jun 6, 2025

31801_dirs_2025-06-06_6263c7c2-e21e-4cf9-b3d1-52d90fca77bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2025-06-05

Reporting Person: Torres Denice (Director)

More from Celldex Therapeutics, Inc.

Interim / Quarterly Report 2026
May 7
Regulatory Filings 2026
May 7
Major Shareholding Notification 2026
May 6
Major Shareholding Notification 2026
Apr 29
Annual Report 2026
Apr 29
Proxy Solicitation & Information Statement 2026
Apr 29
Regulatory Filings 2026
Apr 2
Regulatory Filings 2026
Apr 2
Regulatory Filings 2026
Apr 1
Major Shareholding Notification 2026
Mar 26
View all filings →